ENPLAF ENRICHED PLATELET FACTORS Trademark

Trademark Overview


On Wednesday, September 13, 2017, a trademark application was filed for ENPLAF ENRICHED PLATELET FACTORS with the United States Patent and Trademark Office. The USPTO has given the ENPLAF ENRICHED PLATELET FACTORS trademark a serial number of 87607527. The federal status of this trademark filing is REGISTERED as of Tuesday, May 8, 2018. This trademark is owned by Stemnovo Therapeutics, Inc.. The ENPLAF ENRICHED PLATELET FACTORS trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical or medical purposes using platelet factors extracted from the patient's own blood for treatment of musculoskeletal disorders, including degenerative and inflammatory problems, dermatological conditions focusing on skin, face, neck, hands, breasts rejuvenation and hair restoration, male and female sexual dysfunctions, and accelerating curative effects of dental procedures and general wound healing
enplaf enriched platelet factors

General Information


Serial Number87607527
Word MarkENPLAF ENRICHED PLATELET FACTORS
Filing DateWednesday, September 13, 2017
Status700 - REGISTERED
Status DateTuesday, May 8, 2018
Registration Number5463444
Registration DateTuesday, May 8, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements


Description of MarkThe mark consists of words "Enriched Platelet Factors" shown in stylized, lower-case print, positioned directly above the word "EnPLAF" comprising of four capitalized letters "E", "P", "L", "A" and "F" and one lower-case-letter "n" shown in stylized print, with six (6) circles, of progressively increasing size, extending from the letter "n" in an upward direction, forming an arch over the words "Enriched Platelet Factors".
Goods and ServicesChemical preparations for pharmaceutical or medical purposes using platelet factors extracted from the patient's own blood for treatment of musculoskeletal disorders, including degenerative and inflammatory problems, dermatological conditions focusing on skin, face, neck, hands, breasts rejuvenation and hair restoration, male and female sexual dysfunctions, and accelerating curative effects of dental procedures and general wound healing
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ENRICHED PLATELET FACTORS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 19, 2017
Primary Code005
First Use Anywhere DateWednesday, June 22, 2016
First Use In Commerce DateWednesday, June 22, 2016

Trademark Owner History


Party NameStemnovo Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChicago, IL 60707

Party NameStemnovo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60707

Party NameStemnovo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60707

Trademark Events


Event DateEvent Description
Monday, May 8, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 8, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 12, 2018ASSIGNED TO LIE
Friday, December 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 26, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 26, 2017NON-FINAL ACTION WRITTEN
Saturday, December 16, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 16, 2017NEW APPLICATION ENTERED